A Soluble Guanylate Cyclase Activator Inhibits the Progression of Diabetic Nephropathy in the ZSF1 Rat-Reference-Cited by-同舟云学术

A Soluble Guanylate Cyclase Activator Inhibits the Progression of Diabetic Nephropathy in the ZSF1 Rat

Published:2016-01-04 Issue:3 Volume:356 Page:712-719
ISSN:1521-0103
Container-title:Journal of Pharmacology and Experimental Therapeutics
language:en
Short-container-title:Journal of Pharmacology and Experimental Therapeutics

Author:

Boustany-Kari C. M.,Harrison P. C.,Chen H.,Lincoln K. A.,Qian H. S.,Clifford H.,Wang H.,Zhang X.,Gueneva-Boucheva K.,Bosanac T.,Wong D.,Fryer R. M.,Richman J. G.,Sarko C.,Pullen S. S.

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmacology,Molecular Medicine

Reference24 articles.

1. Renal histologic changes and the outcome in patients with diabetic nephropathy

2. Chronic Treatment With Sildenafil Improves Energy Balance and Insulin Action in High Fat–Fed Conscious Mice

3. Structure and Function of the Kidney in Diabetic Glomerulosclerosis

4. Blood Pressure-Independent Effect of Long-Term Treatment with the Soluble Heme-Independent Guanylyl Cyclase Activator HMR1766 on Progression in a Model of Noninflammatory Chronic Renal Damage

5. Nitric Oxide-Independent Stimulation of Soluble Guanylate Cyclase with BAY 41-2272 in Cardiovascular Disease

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Vasohibin inhibition improves myocardial relaxation in a rat model of heart failure with preserved ejection fraction;Science Translational Medicine;2024-07-17

2. Renal and cardiac effects of the PDE9 inhibitor BAY 73–6691 in 5/6 nephrectomized rats;Pflügers Archiv - European Journal of Physiology;2024-02-02

3. The sGC Activator Runcaciguat Has Kidney Protective Effects and Prevents a Decline of Kidney Function in ZSF1 Rats;International Journal of Molecular Sciences;2023-08-25

4. Soluble Guanylyl Cyclase Activator BI 685509 Reduces Portal Hypertension and Portosystemic Shunting in a Rat Thioacetamide-Induced Cirrhosis Model;Journal of Pharmacology and Experimental Therapeutics;2023-05-25

5. Treatment effects of soluble guanylate cyclase modulation on diabetic kidney disease at single-cell resolution;Cell Reports Medicine;2023-04